|
Status |
Public on Nov 09, 2017 |
Title |
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
RNA-seq was performed to assess gene expression alterations by the addition of serial oncogenic hits (mutant-IDH1, P53 knockdown and ATRX knockdown) in human neural stem cells.
|
|
|
Overall design |
All RNA-seq was performed in duplicates, there are four conditions total. Vector NSCs are the control line and have an empty mCherry vector and a scramble shRNA vector. One hit NSCs express mutant-IDH1 and have a scamble shRNA vector. Two-hit NSCs express mutant IDH1 and have p53 knockdown. Three-hit NSCs express mutant-IDH1, P53 knockdown and ATRX knockdown.
|
|
|
Contributor(s) |
Placantonakis DG, Modrek AS |
Citation(s) |
29091765 |
|
Submission date |
Feb 14, 2017 |
Last update date |
May 15, 2019 |
Contact name |
Aram S Modrek |
E-mail(s) |
Aram.Modrek@nyulangone.org
|
Organization name |
New York University School of Medicine
|
Department |
Radiation Oncology
|
Street address |
460 E 26th Street
|
City |
New York |
State/province |
NY |
ZIP/Postal code |
10016 |
Country |
USA |
|
|
Platforms (1) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
Samples (8)
|
|
This SubSeries is part of SuperSeries: |
GSE94962 |
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown |
|
Relations |
BioProject |
PRJNA374790 |
SRA |
SRP099826 |